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.Y. Hsu
National University of Singapore, Singapore, Singapore
Singapore is a city-state with mixed public-private healthcare
ystem. Antibiotic stewardship programs (ASPs) in Singapore were
nitially independently established by individuals in three public
ospitals, but are currently being implemented in all eight public
ospitals under theMinistry ofHealth’s directive and funding.Most
ospitals employ a system of prospective audit and feedback for a
ariety of broad-spectrum antibiotics, with trained ASP pharma-
ists auditing the prescriptions and infectious diseases physicians
roviding clinical input and decisions for complex cases. One hos-
ital - Tan Tock Seng Hospital - had developed a clinician decision
upport system (CDSS) that has seen considerable local success
n improving appropriate antibiotic prescription. CDSS’s are now
eing developed for the other local hospitals. Current challenges
nclude the need for more systematic training of ASP pharmacists
nd physicians in order to ramp up implementation of ASP across
ospitals, sustainability of theASPmovement, anddeﬁnition of and
greement on key indices for measurement of ASP performance
ithin each hospital.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.098
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ntibiotic stewardship: Differnt challenges in didfferent coun-
ries: Taiwan
.-R. Hsueh
National Taiwan University Hospital, Taipei, Taiwan, R.O.C
Antimicrobial resistance has become a major health problem
orldwide, but marked variations in resistance proﬁles of bacte-
ial pathogens are found among countries and in different patient
ettings, especially in Asian countries. In Taiwan, the emerging
roblem of methicillin-resistant Staphylococcus aureus (MRSA),
xtended-spectrum beta-lactamase (ESBL)-producing, quinolone-
esistant, Klebsiella pneumoniae carbapenemase (KPC)-producing
nterobacteriaceae, and extensively drug-resistant Pseudomonas
eruginosa and Acinetobacter baumannii, is substantial. The dis-
overy of new drugs active against hospital-acquired XDRGNB
nfections to prevent a future medical and social catastrophe
s ongoing. In the interim, appropriate use of currently avail-
ble antibiotics (antibiotic stewardship) and strict adherence of
dequate infection control policy are crucial. Antimicrobial stew-nfectious Diseases 16S (2012) e2–e157 e39
ardship program in Taiwan, initiated by the Taiwan Centers for
Diseases Control and Prevention (Taiwan CDC) in conjunction
with infectious diseases physicians, infectious control experts, and
other multidisciplinary experts, includes establishment of national
inter-sectoral antimicrobial stewardship task force, implement-
ing antimicrobial resistance management strategies, surveillance
of hospital-acquired infections and multidrug-resistant organisms
(MDRO) (TaiwanNosocomial Infection Surveillance System[TNIS]),
conducting hospital infection control, enforcement of appropriate
regulations and audit of antimicrobial use through hospital accred-
itation, inspection and national health insurance payment system.
http://dx.doi.org/10.1016/j.ijid.2012.05.099
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Antimicrobial stewardship in Japan -Methods of operation and
suggested outcomes-
K. Yanagihara
Nagasaki University, Nagasaki, Japan
Antimicrobial stewardship has been deﬁned as “the opti-
mal selection, dosage, and duration of antimicrobial treatment
that results in the best clinical outcome for the treatment or
prevention of infection, with minimal toxicity to the patient
and minimal impact on subsequent resistance. The resis-
tant pathogen such MRSA or multidrug-resistantPseudomonas
aeruginosa(MDRP) is a serious problem in Japan. The outbreak of
multidrug-resistantAcinetobacterspp was reported recently. The
number of ESBL producers has been increasing. Thus, antimicrobial
stewardship programs (involving physicians, pharmacists other
healthcare providers) are increasing in Japan.
Theprescription authorization:Most Japanese hospitals adopt
the prescription authorization. The antimicrobial steward reviews
the antibiotic order for appropriateness at the time it is written.
Speciﬁc antimicrobials are restricted to use by certain prescribers
or units, whereas others must obtain authorization. Each hospital
encourages the use of antimicrobials based on each formulary.
Clinical guidelines and treatment algorithms: Japanese soci-
ety of chemotherapy (JSC) and The Japanese Association for
Infectious Diseases (JAID) have published the guideline for the pre-
scriber to make evidence-based antibiotic choices based on local
antimicrobial resistance patterns, national guidelines, and relevant
clinical factors. They can also provide guidance for de-escalation
and appropriate length of treatment.
Education: JSC have established the education program for the
proper use of antimicrobials. Many doctors are interested in this
program. In some hospitals, the infection control team educate
about antimicrobial stewardship in thegrand rounds, departmental
conferences, house staff teaching.
Pharmacodynamic dose optimization: Pharmacodynamic
dose optimization has been promoting by the societies, Japanese
government and Pharmaceutical companies. Optimal use of cur-
rently available antimicrobials may improve outcomes without
increased risk of toxic effects. The PK/PD properties of antimicro-
bial agents are important to design the dosages. The pharmacists
